TY - JOUR
T1 - The polyproline region of p53 is required to activate apoptosis but not growth arrest
AU - Sakamuro, Daitoku
AU - Sabbatini, Peter
AU - White, Eileen
AU - Prendergast, George C.
N1 - Funding Information:
We are grateful to T Halazonetis for performing the EMSA experiment, providing a murine wt p53 cDNA clone, and for comments and criticisms on the manuscript. We thank W el-Deiry and F Rauscher for plasmids and S Berger, K Elliott, F Rauscher, G Rovera and R Wechsler-Reya for suggestions and criticism. Support from the Wistar Oligonucleotide Synthesis, Flow Cytometry, and Culture Media/Glassware Core Facilities is acknowledged. This work was supported by NIH grant CA60088 (EW), American Cancer Society grant CN-160 (GCP), and USAMRMC Breast Cancer Research Program grant DAMD17-96-1-6324 (GCP). DS is the recipient of the 1996 Christopher Davis Memorial Fellowship. GCP is the recipient of a Junior Faculty Award from the American
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 1997
Y1 - 1997
N2 - p53 is a pivotal regulator of apoptosis but its mechanism of action is obscure. We report that the polyproline (PP) region located between p53's transactivation and DNA binding domains is necessary to induce apoptosis but not cell growth arrest. The PP region was dispensable for DNA binding, inhibition of SAOS-2 tumor cell growth, suppression of E1A + RAS cell transformation, and cell cycle inhibition. A temperature-sensitive dominant inhibitory p53 mutant lacking PP (p53tsΔPP) retained its ability to cooperate with adenovirus E1A in transformation of primary BRK cells. However, while activation of wt p53 induced apoptosis in E1A + p53ts-transformed cells, activation of p53ΔPP induced cell cycle arrest but not apoptosis in E1A + p53tsΔPP-transformed cells. Similarly, PP deletion abolished apoptosis in LoVo colon carcinoma cells, which are killed by wt p53 overexpression. Transactivation was largely unaffected by PP deletion. Significantly, BAX induction was intact, indicating that additional events are required for p53 to induce apoptosis. As a recently described site for familial mutation in at least one breast cancer family, the PP region represents a domain that may be altered in human tumors. We concluded that p53's ability to induce apoptosis is dispensable for inhibiting cell growth and transformation and that the PP region plays a crucial role in apoptotic signaling.
AB - p53 is a pivotal regulator of apoptosis but its mechanism of action is obscure. We report that the polyproline (PP) region located between p53's transactivation and DNA binding domains is necessary to induce apoptosis but not cell growth arrest. The PP region was dispensable for DNA binding, inhibition of SAOS-2 tumor cell growth, suppression of E1A + RAS cell transformation, and cell cycle inhibition. A temperature-sensitive dominant inhibitory p53 mutant lacking PP (p53tsΔPP) retained its ability to cooperate with adenovirus E1A in transformation of primary BRK cells. However, while activation of wt p53 induced apoptosis in E1A + p53ts-transformed cells, activation of p53ΔPP induced cell cycle arrest but not apoptosis in E1A + p53tsΔPP-transformed cells. Similarly, PP deletion abolished apoptosis in LoVo colon carcinoma cells, which are killed by wt p53 overexpression. Transactivation was largely unaffected by PP deletion. Significantly, BAX induction was intact, indicating that additional events are required for p53 to induce apoptosis. As a recently described site for familial mutation in at least one breast cancer family, the PP region represents a domain that may be altered in human tumors. We concluded that p53's ability to induce apoptosis is dispensable for inhibiting cell growth and transformation and that the PP region plays a crucial role in apoptotic signaling.
KW - Apoptosis
KW - Cell cycle
KW - Transformation
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=0030798557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030798557&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1201263
DO - 10.1038/sj.onc.1201263
M3 - Article
C2 - 9285684
AN - SCOPUS:0030798557
SN - 0950-9232
VL - 15
SP - 887
EP - 898
JO - Oncogene
JF - Oncogene
IS - 8
ER -